Validity of Information Employed to Generate Standardized Mortality Ratios

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

In a retrospective cross-sectional study, investigators aimed to valid the variables employed to generate standardized mortality ratio from hospital administrative databases. For this purpose, investigators have compared those variables collected in administrative databases with the information available in patient medical record.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02100293` - Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium	N/A

NCT number	NCT02816320
Study type	Observational
Source	Hospices Civils de Lyon
Contact
Status	Completed
Phase
Start date	July 2014
Completion date	December 2015

Validity of Information Employed to Generate Standardized Mortality Ratios Using Hospital Administrative Databases (RNMH) — RNMH

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms